Enoblituzumab Uses, Dosage, Side Effects and more
Enoblituzumab is under investigation in clinical trial NCT02982941 (Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors).
Trade Name | Enoblituzumab |
Generic | Enoblituzumab |
Enoblituzumab Other Names | Enoblituzumab |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |